Kurlemann

Trial name or title	Single center randomized double blind placebo controlled
Methods
Participants	CMT1A patients genetically carrying the duplication on chromosome 17q11.2 between 5‐16 years
Interventions	Ascorbic acid for 2 years in a dose of 1500 mg/day versus placebo.
Outcomes	Charcot‐Marie‐Tooth neuropathy scale
Starting date	September 2007
Contact information	Prof. Dr . G. Kurlemann, Dept. for Pediatric medicine, Neuropediatrics, Albert‐Schweitzer‐Str. 33, 48129 Münster Prof. Dr. P. Young and Dr. G. Kuhlenbäumer Department of Neurology, University of Muenster, Albert‐Schweitzer‐Str‐ 33, 48129 Muenster, Tel: +49‐251‐8348331, Fax: +49‐251‐8348181, young@uni‐muenster.de, gkuhlen@uni‐munester.de
Notes	Personal communication